About
Oncobit AG develops and commercializes CE-IVDR–marked digital PCR liquid biopsy solutions that quantify circulating tumor DNA from blood samples to enable personalized cancer monitoring and treatment decision-making.
Explore Oncobit AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.